Clinical Trials Directory

Trials / Unknown

UnknownNCT05659199

Extracorporeal Shockwave and Myofascial Release Therapy in Chronic Pelvic Pain Syndrome

Study on the Intervention of Extracorporeal Shockwave Therapy and Myofascial Release Therapy in Chronic Pelvic Pain Syndrome

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Zongda Hospital affiliated to Southeast University · Network
Sex
Male
Age
20 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The primary aims of this research are three folds: (1) To identify more relatively effective interventions for improving pain symptoms in CP/CPPS patients. (2) To ascertain the correlation between PFM elastic modulus and tenderness symptoms. This may find a more objective method of assessing efficacy. (3) To determine the correlation between the intensity of the sympathetic response and the patient's symptoms and to explore other possible pathogenetic mechanisms.

Detailed description

Chronic prostatitis/chronic pelvic pain syndrome is a high prevalent syndrome. Previous studies showed that extracorporeal shockwave therapy and myofascial release therapy could improve quality of life in patients with Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Theoretically, a combined therapy with extracorporeal shockwave therapy and myofascial release therapy is likely to have significant advantages in treating CP/CPPS.

Conditions

Interventions

TypeNameDescription
DEVICEextracorporeal shockwavePatients will be treated with extracorporeal shockwave therapy (ESWT) with bladder lithotomy position, twice a week for 4 weeks, 3,000 individually with a maximum total energy flow density of 0.25 mJ/mm2, rate 3Hz each time. Extracorporeal shockwave (RUIDI.SWT001, Shenzhen, China) can provide a kind of physical spark wave energy, that will be delivered by the probe. The water sac probe will be moved slowly over the groin, perineum and crura of the penis.
BEHAVIORALmyofascial releasepressure was applied at 1 kg/cm2 (within the patient's tolerable range depending on the individual) to the points where patients had a VAS pain score of 4 or more during palpation. Intermittent pressure will be applied for 180-210s at the tenderness until the muscle relaxed.

Timeline

Start date
2023-01-01
Primary completion
2023-12-31
Completion
2024-06-30
First posted
2022-12-21
Last updated
2023-01-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05659199. Inclusion in this directory is not an endorsement.